Molecular Research and Pathological Mechanism of Leukemia

Dear Colleagues,

Hematooncology is a field that dynamically uses new technologies in both diagnosis and treatment. The highest increase in the use of new therapies is observed in patients with blood cancers. The high effectiveness of targeted therapies and immunotherapy is associated with limiting the use of traditional chemotherapy. A personalized therapeutic approach in the treatment of leukemia is associated with a better cure/survival ratio, but it also has its limitations. Should traditional therapeutic approaches be abandoned? How can we improve the diagnosis and treatment efficiency of leukemia patients? How can we effectively eliminate leukemic stem cells? These and other questions will be answered in this Special Issue, which aims to present research in the field of pathophysiology, treatment strategies, and outcomes of leukemia, with a focus on the following:

• The molecular mechanisms involved in leukemia;
• Novel biomarkers for early leukemia diagnosis;
• New therapeutic approaches (target therapies including drug design and development).

Prof. Dr. Sylwia Flis
Prof. Dr. Mirosława Koronkiewicz
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Issues in Molecular Biology is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.